SM-1295 is a potent IAP antagonist designed to disrupt apoptosis regulation by selectively binding XIAP-BIR3, c-IAP1-BIR3, and c-IAP2-BIR3 with high affinity, making it a valuable tool for studying cell survival pathways and therapeutic development.
Usually ships within 24 hours.